Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a post on X:
“Counterview from Dr. Nipun Merchant from Sylvester Comprehensive Cancer Center that won the debate by 100% vs. Michael Lidsky
noting the post-hoc analyses of CAIRO5 demonstrating the role of liver directed therapy in colorectal cancer with elevated OS.”
More posts featuring Cathy Eng.